Free Trial

TriMas (NASDAQ:TRS) Upgraded to Overweight at KeyCorp

TriMas logo with Industrials background

Key Points

  • TriMas has been upgraded from a "hold" rating to a "strong-buy" rating by KeyCorp, with estimates for future earnings growth.
  • The company's stock saw a 5.0% increase, opening at $37.47, with notable performance in recent earnings reporting $0.61 EPS for the last quarter, exceeding analysts' expectations.
  • Insider purchases significantly increased, with Director Adrianne Shapira acquiring 4,000 shares, indicating strong confidence in the company's future.
  • MarketBeat previews the top five stocks to own by October 1st.

KeyCorp upgraded shares of TriMas (NASDAQ:TRS - Free Report) from a sector weight rating to an overweight rating in a report released on Tuesday, August 12th, Marketbeat.com reports. The firm currently has $45.00 target price on the industrial products company's stock. KeyCorp also issued estimates for TriMas' Q3 2025 earnings at $0.57 EPS, Q4 2025 earnings at $0.44 EPS, FY2025 earnings at $2.09 EPS, Q1 2026 earnings at $0.58 EPS, Q2 2026 earnings at $0.73 EPS, Q3 2026 earnings at $0.67 EPS, Q4 2026 earnings at $0.55 EPS and FY2026 earnings at $2.53 EPS.

Several other brokerages have also commented on TRS. BWS Financial restated a "buy" rating and issued a $45.00 price target (up previously from $40.00) on shares of TriMas in a research note on Wednesday, July 30th. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $45.00.

Get Our Latest Stock Analysis on TRS

TriMas Stock Performance

TRS traded down $0.02 on Tuesday, hitting $36.80. 218,663 shares of the company's stock were exchanged, compared to its average volume of 419,544. The firm has a market cap of $1.50 billion, a PE ratio of 40.51 and a beta of 0.66. TriMas has a twelve month low of $19.33 and a twelve month high of $37.49. The stock has a fifty day moving average of $31.09 and a two-hundred day moving average of $26.16. The company has a current ratio of 2.59, a quick ratio of 1.44 and a debt-to-equity ratio of 0.59.

TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.11. The firm had revenue of $274.76 million for the quarter, compared to analyst estimates of $251.18 million. TriMas had a net margin of 3.83% and a return on equity of 11.49%. TriMas's quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.43 earnings per share. TriMas has set its FY 2025 guidance at 1.950-2.100 EPS. On average, research analysts anticipate that TriMas will post 1.69 earnings per share for the current fiscal year.

TriMas Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 12th. Investors of record on Tuesday, August 5th were paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Tuesday, August 5th. TriMas's dividend payout ratio (DPR) is currently 17.58%.

Insider Buying and Selling

In other TriMas news, Director Adrianne Shapira purchased 4,000 shares of the firm's stock in a transaction on Thursday, June 5th. The shares were purchased at an average price of $25.82 per share, for a total transaction of $103,280.00. Following the completion of the transaction, the director owned 8,476 shares in the company, valued at $218,850.32. This represents a 89.37% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Shawn Sedaghat purchased 410,172 shares of the firm's stock in a transaction on Wednesday, May 21st. The stock was acquired at an average price of $25.43 per share, for a total transaction of $10,430,673.96. Following the transaction, the director owned 1,810,821 shares of the company's stock, valued at $46,049,178.03. The trade was a 29.28% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 488,375 shares of company stock worth $12,475,894 in the last quarter. Company insiders own 14.20% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. State of Wyoming acquired a new position in TriMas in the second quarter worth approximately $65,000. Tower Research Capital LLC TRC boosted its stake in TriMas by 280.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,193 shares of the industrial products company's stock worth $120,000 after purchasing an additional 3,091 shares during the period. Captrust Financial Advisors acquired a new position in TriMas in the 2nd quarter worth approximately $355,000. Tidal Investments LLC acquired a new position in TriMas in the 2nd quarter worth approximately $220,000. Finally, Man Group plc acquired a new position in TriMas in the 2nd quarter worth approximately $294,000. Institutional investors and hedge funds own 99.42% of the company's stock.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

See Also

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.